BR Biopharma (NASDAQ:BRBI) Posts Quarterly Earnings Results

BR Biopharma (NASDAQ:BRBI) issued its quarterly earnings data on Tuesday. The company reported $0.05 earnings per share (EPS) for the quarter, FiscalAI reports. The business had revenue of $23.80 million during the quarter.

BR Biopharma Price Performance

Shares of NASDAQ:BRBI traded up $0.06 on Thursday, reaching $7.24. 200 shares of the company traded hands, compared to its average volume of 3,672. The stock has a market capitalization of $85.50 million, a PE ratio of 90.50 and a beta of 0.43. The company’s 50 day moving average is $11.61 and its 200-day moving average is $12.63. BR Biopharma has a fifty-two week low of $6.87 and a fifty-two week high of $16.61.

BR Biopharma Cuts Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, September 4th. Stockholders of record on Monday, August 17th were given a dividend of $0.1415 per share. This is a drop from BR Biopharma’s previous quarterly dividend of $0.1470. The ex-dividend date was Monday, August 17th. This represents a $0.57 dividend on an annualized basis and a dividend yield of 7.8%. BR Biopharma’s payout ratio is currently 525.00%.

Analysts Set New Price Targets

Several equities research analysts recently weighed in on BRBI shares. Weiss Ratings raised shares of BR Biopharma from a “sell (d-)” rating to a “sell (d)” rating in a report on Friday, October 2nd. Citigroup cut shares of BR Biopharma from a “buy” rating to a “hold” rating in a research note on Tuesday, October 27th. One analyst has rated the stock with a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the stock has a consensus rating of “Reduce”.

About BR Biopharma

BRBI BR Partners SA, through its subsidiaries, operates as an investment bank which specializes in providing financial services for entrepreneurs and families principally in Brazil. It offers financial advisory services for mergers and acquisitions, capital markets, board services, shareholders, special situations and restructuring, pre-IPO, and privatization; and wealth management services. BRBI BR Partners SA is based in S?o Paulo, Brazil.